IMMUNOVANT INC (IMVT) Stock Income Statement
USA - NASDAQ:IMVT - US45258J1025 - Common Stock
16.16 USD
-0.64 (-3.81%)
16.23 USD
+0.07 (+0.43%)
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 471.09M | 438.15M | 270.21M | 208.28M | 156.03M | |||
| Research and Development | 386.64M | 360.92M | 212.93M | 160.26M | 101.81M | |||
| Selling, General, and Administrative Expenses | 84.45M | 77.23M | 57.28M | 48.02M | 54.23M | |||
| Operating Income | -471.09M | -438.15M | -270.21M | -208.28M | -156.03M | |||
| Interest Income/Expense | 23.89M | 24.73M | 24.95M | 7.58M | N/A | |||
| Other Income/Expense | 1.63M | 471.00K | -1.01M | -250.00K | -780.00K | |||
| Non Recurring Items | N/A | 0.00 | -12.50M | -10.00M | N/A | |||
| Income Before Taxes | -445.58M | -412.95M | -258.77M | -210.95M | -156.81M | |||
| Income Tax | 1.73M | 891.00K | 567.00K | 10.00K | -80.00K | |||
| Net Income | -447.30M | -413.84M | -259.34M | -210.96M | -156.73M | |||
| EBITDA | -470.69M | -437.77M | -269.98M | -208.09M | -155.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.85 | -2.73 | -1.88 | -1.71 | -1.43 | |||
| Non GAAP EPS | -2.85 | -2.74 | -1.90 | -1.71 | -1.43 | |||
| Statistics | ||||||||
All data in USD